Target intelligence / Profile preview

Novel transcript, antisense to ACSM5 (ENSG00000262995)

Target: ENSG00000262995
Molecular classification: Other (non-coding RNA)

Overview

Novel transcript, antisense to ACSM5" (ENSG00000262995) is a non-coding RNA gene located antisense to the ACSM5 gene. It does not encode a protein and is not characterized as a functional receptor, enzyme, transporter, or other conventional therapeutic target. No evidence supports a biological function, disease role, or interaction with drugs. This entry, while an annotated locus, is not considered a traditional drug target and may only be relevant in non-coding transcriptomics or regulatory RNA studies[1].

Other names: Novel transcript, antisense to ACSM5

Beyond the preview

Go deeper on Novel transcript, antisense to ACSM5 (ENSG00000262995).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to ACSM5 (ENSG00000262995).

Explore the full profile